Based on our data, we presented a hypothetical model that ZBTB16 might form complexes with ZBTB28 and BCL6, respectively, and function as a tumor suppressor through inhibition of BCL6 and promotion of ZBTB28 (Fig. 8). The gene discussed is BCL6B; the disease is neoplasm.